Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Ventech II currently holds 1,431,814 shares of EYEGATE PHARMACEUTICALS INC (EYEG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Ventech II has been a net buyer of EYEG stock. They have purchased $896.7K and sold $194.7K worth of shares.
Capital Ventech II's most recent insider trade was on Mar 13, 2017, when they sold 4,419 shares at $2.80 per share.
Capital Ventech II serves as Executive at EYEGATE PHARMACEUTICALS INC (EYEG). They have executed 19 insider transactions totaling $1.1M over their tenure at the company.
Capital Ventech II holds the position of Executive at EYEGATE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Capital Ventech II has shown a buying trading pattern, with $896.7K in total purchases and $194.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Ventech II was on Feb 19, 2015, when they sold $1.0M worth of EYEG shares. This transaction involved 241,270 shares at $4.20 per share.
Capital Ventech II currently owns 1,431,814 shares of EYEGATE PHARMACEUTICALS INC (EYEG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Ventech II's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Ventech II has 19 Form 4 filings on record as an insider at EYEGATE PHARMACEUTICALS INC.
Set alerts for Capital Ventech II and 40,000+ other insiders.